Open Beta
MetriLume

US marketsPTCT

SEC-sourced researchBeta

PTCT

PTC THERAPEUTICS, INC.

Company comparison ↗

Data passport

CIK
0001070081
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 937,822,000.0000 USD; December 2024: 806,780,000.0000 USD; December 2025: 1,730,655,000.0000 USD1.7B USD0 USD0December 2023December 2024December 2025
PTCT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023937,822,000.0000Feb 19, 2026
December 2024806,780,000.0000Feb 19, 2026
December 20251,730,655,000.0000Feb 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,730,655,000.0000682,644,000.0000711,196,000.00002,898,767,000.00003,104,080,000.0000Feb 19, 2026
December 2024806,780,000.0000-363,295,000.0000-107,688,000.00001,705,024,000.00002,803,095,000.0000Feb 19, 2026
December 2023937,822,000.0000-626,604,000.0000-158,418,000.0000——Feb 19, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$1.73BDecember 2025Feb 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$806.78MDecember 2024Feb 19, 202610-K
Net incomeNetIncomeLoss$682.64MDecember 2025Feb 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$711.2MDecember 2025Feb 19, 202610-K
Total assetsAssets$2.9BDecember 2025Feb 19, 202610-K
Total liabilitiesLiabilities$3.1BDecember 2025Feb 19, 202610-K

New filings

Explore methodology ↗